Olema makes investor presentation available for JP Morgan Conference; no financial details disclosed

Olema Pharmaceuticals, Inc.

Presentation furnished as Exhibit 99.1, dated January 8, 2024.
No specific clinical, financial, or pipeline updates provided in the filed text.
Presentation is for the JP Morgan Healthcare Conference in January 2024.

item 7.01 item 9.01

Olema Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-002741

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.